The DOI matches its Crossref record; 141 of the 141 references it cites were found in a registry or an index.
The Role of Inflammation in Depression and Fatigue
Open accessAbstract
Depression and fatigue are conditions responsible for heavy global societal burden, especially in patients already suffering from chronic diseases. These symptoms have been identified by those affected as some of the most disabling symptoms which affect the quality of life and productivity of the individual. While many factors play a role in the development of depression and fatigue, both have been associated with increased inflammatory activation of the immune system affecting both the periphery and the central nervous system (CNS). This is further supported by the well-described association between diseases that involve immune activation and these symptoms in autoimmune disorders, such as multiple sclerosis and immune system activation in response to infections, like sepsis. Treatments for depression also support this immunopsychiatric link. Antidepressants have been shown to decrease inflammation, while higher levels of baseline inflammation predict lower treatment efficacy for most treatments. Those patients with higher initial immune activation may on the other hand be more responsive to treatments targeting immune pathways, which have been found to be effective in treating depression and fatigue in some cases. These results show strong support for the hypothesis that depression and fatigue are associated with an increased activation of the immune system which may serve as a valid target for treatment. Further studies should focus on the pathways involved in these symptoms and the development of treatments that target those pathways will help us to better understand these conditions and devise more targeted treatments.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Vos, T., Abajobir, A. A., Abate, K. H., Abbafati, C., Abbas, K. M., Abd-Allah, F., Abdulkader, R. S., Abdulle, A. M., Abebo, T. A., Abera, S. F., et al. (2017) · The Lancet · doi:10.1016/s0140-6736(17)32154-2 · Cited by 13,220
Molecular Mechanisms of Depression: Perspectives on New Treatment Strategies
Lang, U. E., & Borgwardt, S. (2013) · Cellular Physiology and Biochemistry · doi:10.1159/000350094 · Cited by 8,475
Glutamate neurotoxicity and diseases of the nervous system
CHOI, D. (1988) · Neuron · doi:10.1016/0896-6273(88)90162-6 · Cited by 7,972
From inflammation to sickness and depression: when the immune system subjugates the brain
Dantzer, R., O'Connor, J. C., Freund, G. G., Johnson, R. W., & Kelley, K. W. (2008) · Nature Reviews Neuroscience · doi:10.1038/nrn2297 · Cited by 7,395
Rush, A. J., Trivedi, M. H., Wisniewski, S. R., Nierenberg, A. A., Stewart, J. W., Warden, D., Niederehe, G., Thase, M. E., Lavori, P. W., Lebowitz, B. D., et al. (2006) · American Journal of Psychiatry · doi:10.1176/ajp.2006.163.11.1905 · Cited by 5,643 · cited 1×
“Given that a third of depressed patients are treatment resistant even after four successive treatment steps (137), the exploration of the immune system as a treatment target is a legitimate area of interest, especially in those with higher baseline inflammation.”
BackgroundA Meta-Analysis of Cytokines in Major Depression
Dowlati, Y., Herrmann, N., Swardfager, W., Liu, H., Sham, L., Reim, E. K., & Lanctôt, K. L. (2010) · Biological Psychiatry · doi:10.1016/j.biopsych.2009.09.033 · Cited by 4,729
Depression, chronic diseases, and decrements in health: results from the World Health Surveys
Moussavi, S., Chatterji, S., Verdes, E., Tandon, A., Patel, V., & Ustun, B. (2007) · The Lancet · doi:10.1016/s0140-6736(07)61415-9 · Cited by 4,070
The role of inflammation in depression: from evolutionary imperative to modern treatment target
Miller, A. H., & Raison, C. L. (2016) · Nature Reviews Immunology · doi:10.1038/nri.2015.5 · Cited by 3,942 · cited 1×
“The use of non-steroidal anti-inflammatory drugs (NSAIDs) as an add-on to standard antidepressant therapy should however be done carefully due to the role innate immune response plays in normal neurological functions (23), and especially since the antidepressant effect of SSRIs can be attenuated by anti-inflammatory t…”
BackgroundThe Prevalence of Comorbid Depression in Adults With Diabetes
Anderson, R. J., Freedland, K. E., Clouse, R. E., & Lustman, P. J. (2001) · Diabetes Care · doi:10.2337/diacare.24.6.1069 · Cited by 3,926
The Epidemiology of Depression Across Cultures
Kessler, R. C., & Bromet, E. J. (2013) · Annual Review of Public Health · doi:10.1146/annurev-publhealth-031912-114409 · Cited by 2,657
Cancer-related fatigue—mechanisms, risk factors, and treatments
Bower, J. E. (2014) · Nature Reviews Clinical Oncology · doi:10.1038/nrclinonc.2014.127 · Cited by 1,666
Raison, C. L., Rutherford, R. E., Woolwine, B. J., Shuo, C., Schettler, P., Drake, D. F., Haroon, E., & Miller, A. H. (2013) · JAMA Psychiatry · doi:10.1001/2013.jamapsychiatry.4 · Cited by 1,617
Peripheral cytokine and chemokine alterations in depression: a meta‐analysis of 82 studies
Köhler, C. A., Freitas, T. H., Maes, M., de Andrade, N. Q., Liu, C. S., Fernandes, B. S., Stubbs, B., Solmi, M., Veronese, N., Herrmann, N., et al. (2017) · Acta Psychiatrica Scandinavica · doi:10.1111/acps.12698 · Cited by 1,443 · cited 2×
“In a more recent, larger scale meta-analysis a greater range of changes have been described in people with depression, including higher levels of TNFα, IL-6, IL-13, IL-18, IL-12, IL-1RA, and sTNFR2, along with a decrease in the proinflammatory cytokine IFNγ (18).”
BackgroundAli, S., Stone, M. A., Peters, J. L., Davies, M. J., & Khunti, K. (2006) · Diabetic Medicine · doi:10.1111/j.1464-5491.2006.01943.x · Cited by 1,276
Inflammatory cytokines in depression: neurobiological mechanisms and therapeutic implications
Felger, J. C., & Lotrich, F. E. (2013) · Neuroscience · doi:10.1016/j.neuroscience.2013.04.060 · Cited by 1,180
The blood-brain barrier in systemic inflammation
Varatharaj, A., & Galea, I. (2017) · Brain, Behavior, and Immunity · doi:10.1016/j.bbi.2016.03.010 · Cited by 1,172 · cited 1×
“CNS inflammation has also demonstrated that it disrupts the BBB in both MS and its animal model, experimental autoimmune encephalitis (EAE), allowing for easier entry of both cytokines and immune cells into the brain (47, 48).”
BackgroundEnhancing Recovery From Sepsis: A Review
Prescott, H. C., & Angus, D. C. (2018) · JAMA · doi:10.1001/jama.2017.17687 · Cited by 1,059
The impact of fatigue on patients with multiple sclerosis
Fisk, J. D., Pontefract, A., Ritvo, P. G., Archibald, C. J., & Murray, T. J. (1994) · Canadian Journal of Neurological Sciences / Journal Canadien des Sciences Neurologiques · doi:10.1017/s0317167100048691 · Cited by 1,025 · cited 1×
“60% reporting that it makes their other symptoms worse (11).”
BackgroundThe Relationship of Depression and Stressors to Immunological Assays: A Meta-Analytic Review
Zorrilla, E. P., Luborsky, L., McKay, J. R., Rosenthal, R., Houldin, A., Tax, A., McCorkle, R., Seligman, D. A., & Schmidt, K. (2001) · Brain, Behavior, and Immunity · doi:10.1006/brbi.2000.0597 · Cited by 995
Köhler, O., Benros, M. E., Nordentoft, M., Farkouh, M. E., Iyengar, R. L., Mors, O., & Krogh, J. (2014) · JAMA Psychiatry · doi:10.1001/jamapsychiatry.2014.1611 · Cited by 941
The prevalence of depression in rheumatoid arthritis: a systematic review and meta-analysis
Matcham, F., Rayner, L., Steer, S., & Hotopf, M. (2013) · Rheumatology · doi:10.1093/rheumatology/ket169 · Cited by 928
Hannestad, J., DellaGioia, N., & Bloch, M. (2011) · Neuropsychopharmacology · doi:10.1038/npp.2011.132 · Cited by 914
Khandaker, G. M., Pearson, R. M., Zammit, S., Lewis, G., & Jones, P. B. (2014) · JAMA Psychiatry · doi:10.1001/jamapsychiatry.2014.1332 · Cited by 846
Inflammation: Depression Fans the Flames and Feasts on the Heat
Kiecolt-Glaser, J. K., Derry, H. M., & Fagundes, C. P. (2015) · American Journal of Psychiatry · doi:10.1176/appi.ajp.2015.15020152 · Cited by 844
Capuron, L. (2002) · Neuropsychopharmacology · doi:10.1016/s0893-133x(01)00407-9 · Cited by 797
Takeuchi, H., Jin, S., Wang, J., Zhang, G., Kawanokuchi, J., Kuno, R., Sonobe, Y., Mizuno, T., & Suzumura, A. (2006) · Journal of Biological Chemistry · doi:10.1074/jbc.m600504200 · Cited by 749
Cytokine-induced sickness behaviour: a neuroimmune response to activation of innate immunity
Dantzer, R. (2004) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2004.07.040 · Cited by 743
Cytokine Production and Treatment Response in Major Depressive Disorder
Lanquillon, S. (2000) · Neuropsychopharmacology · doi:10.1016/s0893-133x(99)00134-7 · Cited by 735
Depression in multiple sclerosis: a review
Siegert, R. J. (2005) · Journal of Neurology, Neurosurgery & Psychiatry · doi:10.1136/jnnp.2004.054635 · Cited by 718
Cytokine-induced sickness behavior
Kelley, K. W., Bluthé, R.-M., Dantzer, R., Zhou, J.-H., Shen, W.-H., Johnson, R. W., & Broussard, S. R. (2003) · Brain, Behavior, and Immunity · doi:10.1016/s0889-1591(02)00077-6 · Cited by 716
The link between depression and diabetes: the search for shared mechanisms
Moulton, C. D., Pickup, J. C., & Ismail, K. (2015) · The Lancet Diabetes & Endocrinology · doi:10.1016/s2213-8587(15)00134-5 · Cited by 670
Kappelmann, N., Lewis, G., Dantzer, R., Jones, P. B., & Khandaker, G. M. (2018) · Molecular Psychiatry · doi:10.1038/mp.2016.167 · Cited by 659 · cited 3×
“Anti-IL-6 Human: antidepressant effect (124)”
BackgroundInfluentialInflammation-Induced Anhedonia: Endotoxin Reduces Ventral Striatum Responses to Reward
Eisenberger, N. I., Berkman, E. T., Inagaki, T. K., Rameson, L. T., Mashal, N. M., & Irwin, M. R. (2010) · Biological Psychiatry · doi:10.1016/j.biopsych.2010.06.010 · Cited by 596
Neuroimmune mechanisms of depression
Hodes, G. E., Kana, V., Menard, C., Merad, M., & Russo, S. J. (2015) · Nature Neuroscience · doi:10.1038/nn.4113 · Cited by 585
Gimeno, D., Kivimäki, M., Brunner, E. J., Elovainio, M., De Vogli, R., Steptoe, A., Kumari, M., Lowe, G. D. O., Rumley, A., Marmot, M. G., et al. (2009) · Psychological Medicine · doi:10.1017/s0033291708003723 · Cited by 561
The link between multiple sclerosis and depression
Feinstein, A., Magalhaes, S., Richard, J.-F., Audet, B., & Moore, C. (2014) · Nature Reviews Neurology · doi:10.1038/nrneurol.2014.139 · Cited by 523
Quality of life in multiple sclerosis: the impact of depression, fatigue and disability
Amato, M. P., Ponziani, G., Rossi, F., Liedl, C. L., Stefanile, C., & Rossi, L. (2001) · Multiple Sclerosis Journal · doi:10.1177/135245850100700511 · Cited by 506
Meyers, C. A., Albitar, M., & Estey, E. (2005) · Cancer · doi:10.1002/cncr.21234 · Cited by 459
Inflammatory Markers at Hospital Discharge Predict Subsequent Mortality after Pneumonia and Sepsis
Yende, S., D'Angelo, G., Kellum, J. A., Weissfeld, L., Fine, J., Welch, R. D., Kong, L., Carter, M., & Angus, D. C. (2008) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.200712-1777oc · Cited by 434
Dahl, J., Ormstad, H., Aass, H. C. D., Malt, U. F., Bendz, L. T., Sandvik, L., Brundin, L., & Andreassen, O. A. (2014) · Psychoneuroendocrinology · doi:10.1016/j.psyneuen.2014.03.019 · Cited by 424 · cited 1×
“Other recent studies have also looked at exercise, transcranial direct current stimulation (tDCS), and standard of care treatment and shown that the levels of a variety of circulating cytokines generally decrease following treatment, although there is no agreement on the correlation with improvement of depressive symp…”
BackgroundUher, R., Tansey, K. E., Dew, T., Maier, W., Mors, O., Hauser, J., Dernovsek, M. Z., Henigsberg, N., Souery, D., Farmer, A., et al. (2014) · American Journal of Psychiatry · doi:10.1176/appi.ajp.2014.14010094 · Cited by 418
Psychiatric Complications of Long-term Interferon Alfa Therapy
Renault, P. F. (1987) · Archives of Internal Medicine · doi:10.1001/archinte.1987.00370090055011 · Cited by 413
Cause of death in patients attending multiple sclerosis clinics
Sadovnick, A. D., Eisen, K., Ebers, G. C., & Paty, D. W. (1991) · Neurology · doi:10.1212/wnl.41.8.1193 · Cited by 401
Evidence Report on the Occurrence, Assessment, and Treatment of Fatigue in Cancer Patients
Lawrence, D. P. (2004) · Journal of the National Cancer Institute Monographs · doi:10.1093/jncimonographs/lgh027 · Cited by 396
Interleukin-1β: A New Regulator of the Kynurenine Pathway Affecting Human Hippocampal Neurogenesis
Zunszain, P. A., Anacker, C., Cattaneo, A., Choudhury, S., Musaelyan, K., Myint, A. M., Thuret, S., Price, J., & Pariante, C. M. (2012) · Neuropsychopharmacology · doi:10.1038/npp.2011.277 · Cited by 388
Fatigue in multiple sclerosis: an example of cytokine mediated sickness behaviour?
Heesen, C. (2006) · Journal of Neurology, Neurosurgery & Psychiatry · doi:10.1136/jnnp.2005.065805 · Cited by 345
Immune suppression and immune activation in depression
Blume, J., Douglas, S. D., & Evans, D. L. (2011) · Brain, Behavior, and Immunity · doi:10.1016/j.bbi.2010.10.008 · Cited by 338 · cited 1×
“In contrast, a suppression of immune responses has also been described in patients with depression (41).”
BackgroundDisruption of central nervous system barriers in multiple sclerosis
Alvarez, J. I., Cayrol, R., & Prat, A. (2011) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/j.bbadis.2010.06.017 · Cited by 334
An examination of suicidal intent in patients with multiple sclerosis
Feinstein, A. (2002) · Neurology · doi:10.1212/wnl.59.5.674 · Cited by 327
Zhang, L., Fu, T., Yin, R., Zhang, Q., & Shen, B. (2017) · BMC Psychiatry · doi:10.1186/s12888-017-1234-1 · Cited by 324
Different receptor mechanisms mediate the pyrogenic and behavioral effects of interleukin 1.
Kent, S., Bluthe, R. M., Dantzer, R., Hardwick, A. J., Kelley, K. W., Rothwell, N. J., & Vannice, J. L. (1992) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.89.19.9117 · Cited by 322
Prevalence and concurrence of anxiety, depression and fatigue over time in multiple sclerosis
Wood, B., van der Mei, I., Ponsonby, A.-L., Pittas, F., Quinn, S., Dwyer, T., Lucas, R., & Taylor, B. (2013) · Multiple Sclerosis Journal · doi:10.1177/1352458512450351 · Cited by 294
TNFα disrupts blood brain barrier integrity to maintain prolonged depressive-like behavior in mice
Cheng, Y., Desse, S., Martinez, A., Worthen, R. J., Jope, R. S., & Beurel, E. (2018) · Brain, Behavior, and Immunity · doi:10.1016/j.bbi.2018.02.003 · Cited by 292
Leighton, S. P., Nerurkar, L., Krishnadas, R., Johnman, C., Graham, G. J., & Cavanagh, J. (2018) · Molecular Psychiatry · doi:10.1038/mp.2017.205 · Cited by 291
Warner-Schmidt, J. L., Vanover, K. E., Chen, E. Y., Marshall, J. J., & Greengard, P. (2011) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1104836108 · Cited by 291
Pro-inflammatory cytokines and treatment response to escitaloprsam in major depressive disorder
Eller, T., Vasar, V., Shlik, J., & Maron, E. (2008) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/j.pnpbp.2007.09.015 · Cited by 290
Inflammation and the two-hit hypothesis of schizophrenia
Feigenson, K. A., Kusnecov, A. W., & Silverstein, S. M. (2014) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2013.11.006 · Cited by 282
Fatigue in multiple sclerosis: relationship to depression, disability, and disease pattern
Kroencke, D. C., Lynch, S. G., & Denney, D. R. (2000) · Multiple Sclerosis Journal · doi:10.1177/135245850000600213 · Cited by 253 · cited 1×
“[interferes] with usual and desired activities” (7), is strongly associated with mental health symptoms such as depression and anxiety (8, 9).”
BackgroundEffect of antidepressant treatment on peripheral inflammation markers – A meta-analysis
Więdłocha, M., Marcinowicz, P., Krupa, R., Janoska-Jaździk, M., Janus, M., Dębowska, W., Mosiołek, A., Waszkiewicz, N., & Szulc, A. (2018) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/j.pnpbp.2017.04.026 · Cited by 233
A prospective study of patterns of fatigue in multiple sclerosis
Lerdal, A., Gulowsen Celius, E., Krupp, L., & Dahl, A. A. (2007) · European Journal of Neurology · doi:10.1111/j.1468-1331.2007.01974.x · Cited by 232
Higher plasma interleukin-6 (IL-6) level is associated with SSRI- or SNRI-refractory depression
Yoshimura, R., Hori, H., Ikenouchi-Sugita, A., Umene-Nakano, W., Ueda, N., & Nakamura, J. (2009) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/j.pnpbp.2009.03.020 · Cited by 227
Gene expression in major depressive disorder
Jansen, R., Penninx, B. W. J. H., Madar, V, Xia, K., Milaneschi, Y., Hottenga, J. J., Hammerschlag, A. R., Beekman, A., van der Wee, N., Smit, J. H., et al. (2016) · Molecular Psychiatry · doi:10.1038/mp.2015.57 · Cited by 224 · cited 1×
“More recent studies have shown that both can occur in the same patient, with NK and regulatory T cell (TReg) activity suppressed and inflammatory monocytes activated (42, 43).”
BackgroundDepression, inflammation, and pain in patients with rheumatoid arthritis.
Kojima, M., Kojima, T., Suzuki, S., Oguchi, T., Oba, M., Tsuchiya, H., Sugiura, F., Kanayama, Y., Furukawa, T. A., Tokudome, S., et al. (2009) · Arthritis Care & Research · doi:10.1002/art.24647 · Cited by 217
Rethorst, C. D., Toups, M. S., Greer, T. L., Nakonezny, P. A., Carmody, T. J., Grannemann, B. D., Huebinger, R. M., Barber, R. C., & Trivedi, M. H. (2013) · Molecular Psychiatry · doi:10.1038/mp.2012.125 · Cited by 211
Ohgi, Y., Futamura, T., Kikuchi, T., & Hashimoto, K. (2013) · Pharmacology Biochemistry and Behavior · doi:10.1016/j.pbb.2012.12.003 · Cited by 207
Co-occurrence and symptomatology of fatigue and depression
Corfield, E. C., Martin, N. G., & Nyholt, D. R. (2016) · Comprehensive Psychiatry · doi:10.1016/j.comppsych.2016.08.004 · Cited by 201
Mark, K. S., Trickler, W. J., & Miller, D. W. (2001) · PubMed · Cited by 197
Mohr, D. C., Goodkin, D. E., Islar, J., Hauser, S. L., & Genain, C. P. (2001) · Archives of Neurology · doi:10.1001/archneur.58.7.1081 · Cited by 190
Novel therapeutic targets in depression: Minocycline as a candidate treatment
Soczynska, J. K., Mansur, R. B., Brietzke, E., Swardfager, W., Kennedy, S. H., Woldeyohannes, H. O., Powell, A. M., Manierka, M. S., & McIntyre, R. S. (2012) · Behavioural Brain Research · doi:10.1016/j.bbr.2012.07.026 · Cited by 189
A meta-analysis of chemokines in major depression
Eyre, H. A., Air, T., Pradhan, A., Johnston, J., Lavretsky, H., Stuart, M. J., & Baune, B. T. (2016) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/j.pnpbp.2016.02.006 · Cited by 188
Kiraly, D. D., Horn, S. R., Van Dam, N. T., Costi, S., Schwartz, J., Kim-Schulze, S., Patel, M., Hodes, G. E., Russo, S. J., Merad, M., et al. (2017) · Translational Psychiatry · doi:10.1038/tp.2017.31 · Cited by 186
Trial of Minocycline in a Clinically Isolated Syndrome of Multiple Sclerosis
Metz, L. M., Li, D. K. B., Traboulsee, A. L., Duquette, P., Eliasziw, M., Cerchiaro, G., Greenfield, J., Riddehough, A., Yeung, M., Kremenchutzky, M., et al. (2017) · New England Journal of Medicine · doi:10.1056/nejmoa1608889 · Cited by 184
Increased incidence of psychiatric disorders in immune-mediated inflammatory disease
Marrie, R. A., Walld, R., Bolton, J. M., Sareen, J., Walker, J. R., Patten, S. B., Singer, A., Lix, L. M., Hitchon, C. A., El-Gabalawy, R., et al. (2017) · Journal of Psychosomatic Research · doi:10.1016/j.jpsychores.2017.07.015 · Cited by 184
Electroconvulsive therapy, depression, the immune system and inflammation: A systematic review
Yrondi, A., Sporer, M., Péran, P., Schmitt, L., Arbus, C., & Sauvaget, A. (2018) · Brain Stimulation · doi:10.1016/j.brs.2017.10.013 · Cited by 182
Rosenblat, J. D., & McIntyre, R. S. (2018) · Journal of Affective Disorders · doi:10.1016/j.jad.2017.10.042 · Cited by 178
Blank, T., Detje, C. N., Spieß, A., Hagemeyer, N., Brendecke, S. M., Wolfart, J., Staszewski, O., Zöller, T., Papageorgiou, I., Schneider, J., et al. (2016) · Immunity · doi:10.1016/j.immuni.2016.04.005 · Cited by 177
Cytokine mRNA expression in patients with multiple sclerosis and fatigue
Flachenecker, P., Bihler, I., Weber, F., Gottschalk, M., Toyka, K. V., & Rieckmann, P. (2004) · Multiple Sclerosis Journal · doi:10.1191/1352458504ms991oa · Cited by 169
Lipopolysaccharide-induced sepsis induces long-lasting affective changes in the mouse
Anderson, S. T., Commins, S., Moynagh, P. N., & Coogan, A. N. (2015) · Brain, Behavior, and Immunity · doi:10.1016/j.bbi.2014.07.007 · Cited by 168
Frank, M. G., Weber, M. D., Watkins, L. R., & Maier, S. F. (2015) · Neurobiology of Stress · doi:10.1016/j.ynstr.2015.12.004 · Cited by 164
Deficiencies of the T and natural killer cell system in major depressive disorder
Grosse, L., Hoogenboezem, T., Ambrée, O., Bellingrath, S., Jörgens, S., de Wit, H. J., Wijkhuijs, A. M., Arolt, V., & Drexhage, H. A. (2016) · Brain, Behavior, and Immunity · doi:10.1016/j.bbi.2015.12.003 · Cited by 163
TNF-α-mediated anxiety in a mouse model of multiple sclerosis
Haji, N., Mandolesi, G., Gentile, A., Sacchetti, L., Fresegna, D., Rossi, S., Musella, A., Sepman, H., Motta, C., Studer, V., et al. (2012) · Experimental Neurology · doi:10.1016/j.expneurol.2012.07.010 · Cited by 158
Everyday Cognitive Failure in Sarcoidosis: The Prevalence and the Effect of Anti-TNF-α Treatment
Elfferich, M., Nelemans, P. J., Ponds, R., Vries, J. D., Wijnen, P. A. H. M., & Drent, M. (2010) · Respiration · doi:10.1159/000314225 · Cited by 148
Laake, J.-P., Stahl, D. R., Amiel, S. A., Petrak, F., Sherwood, R. A., Pickup, J. C., & Ismail, K. (2014) · Diabetes Care · doi:10.2337/dc13-2522 · Cited by 148
Comorbidity between depression and asthma via immune-inflammatory pathways: a meta-analysis
Jiang, M., Qin, P., & Yang, X. (2014) · Journal of Affective Disorders · doi:10.1016/j.jad.2014.04.027 · Cited by 146
Depression and Immunity: Inflammation and Depressive Symptoms in Multiple Sclerosis
Gold, S. M., & Irwin, M. R. (2009) · Immunology and Allergy Clinics of North America · doi:10.1016/j.iac.2009.02.008 · Cited by 146
Rising incidence of psychiatric disorders before diagnosis of immune-mediated inflammatory disease
Marrie, R. A., Walld, R., Bolton, J. M., Sareen, J., Walker, J. R., Patten, S. B., Singer, A., Lix, L. M., Hitchon, C. A., El-Gabalawy, R., et al. (2019) · Epidemiology and Psychiatric Sciences · doi:10.1017/s2045796017000579 · Cited by 144
Patejdl, R., Penner, I. K., Noack, T. K., & Zettl, U. K. (2016) · Autoimmunity Reviews · doi:10.1016/j.autrev.2015.11.005 · Cited by 141
Zheng, L., Kaneko, N., & Sawamoto, K. (2015) · Frontiers in Cellular Neuroscience · doi:10.3389/fncel.2015.00005 · Cited by 134
Neuroimmune and neuroendocrine abnormalities in depression: two sides of the same coin
Horowitz, M. A., & Zunszain, P. A. (2015) · Annals of the New York Academy of Sciences · doi:10.1111/nyas.12781 · Cited by 129
Fatigue in multiple sclerosis persists over time: A longitudinal study
Téllez, N., Río, J., Tintoré, M., Nos, C., Galán, I., & Montalbán, X. (2006) · Journal of Neurology · doi:10.1007/s00415-006-0247-3 · Cited by 129
Rescue of IL-1β-induced reduction of human neurogenesis by omega-3 fatty acids and antidepressants
Borsini, A., Alboni, S., Horowitz, M. A., Tojo, L. M., Cannazza, G., Su, K.-P., Pariante, C. M., & Zunszain, P. A. (2017) · Brain, Behavior, and Immunity · doi:10.1016/j.bbi.2017.05.006 · Cited by 126
Neuroinflammatory priming to stress is differentially regulated in male and female rats
Fonken, L. K., Frank, M. G., Gaudet, A. D., D’Angelo, H. M., Daut, R. A., Hampson, E. C., Ayala, M. T., Watkins, L. R., & Maier, S. F. (2018) · Brain Behavior and Immunity · doi:10.1016/j.bbi.2018.03.005 · Cited by 122
Zabad, R. K., Metz, L. M., Todoruk, T. R., Zhang, Y., Mitchell, J. R., Yeung, M., Patry, D. G., Bell, R. B., & Yong, V. W. (2007) · Multiple Sclerosis Journal · doi:10.1177/1352458506070319 · Cited by 120
Biologic interventions for fatigue in rheumatoid arthritis
Almeida, C., Choy, E., HEWLETT, S. E., Kirwan, J., Cramp, F. L., Chalder, T., Pollock, J. I., & Christensen, R. (2016) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd008334.pub2 · Cited by 119
Fatigue is not associated with raised inflammatory markers in multiple sclerosis
Giovannoni, G., Thompson, A. J., Miller, D. H., & Thompson, E. J. (2001) · Neurology · doi:10.1212/wnl.57.4.676 · Cited by 116
Impact of antidepressants on cytokine production of depressed patients in Vitro
Munzer, A., Sack, U., Mergl, R., Schönherr, J., Petersein, C., Bartsch, S., Kirkby, K., Bauer, K., & Himmerich, H. (2013) · Toxins · doi:10.3390/toxins5112227 · Cited by 114
Symptoms of Depression in Survivors of Severe Sepsis: A Prospective Cohort Study of Older Americans
Davydow, D. S., Hough, C. L., Langa, K. M., & Iwashyna, T. J. (2013) · American Journal of Geriatric Psychiatry · doi:10.1016/j.jagp.2013.01.017 · Cited by 109
Imipramine attenuates neuroinflammatory signaling and reverses stress-induced social avoidance
Ramirez, K., Shea, D. T., McKim, D. B., Reader, B. F., & Sheridan, J. F. (2015) · Brain, Behavior, and Immunity · doi:10.1016/j.bbi.2015.01.016 · Cited by 108
miR-155 Is Essential for Inflammation-Induced Hippocampal Neurogenic Dysfunction
Woodbury, M. E., Freilich, R. W., Cheng, C. J., Asai, H., Ikezu, S., Boucher, J. D., Slack, F. J., & Ikezu, T. (2015) · Journal of Neuroscience · doi:10.1523/jneurosci.4790-14.2015 · Cited by 100
Liu, H., Luiten, P. G. M., Eisel, U. L. M., DeJongste, M. J. L., & Schoemaker, R. G. (2013) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2013.02.004 · Cited by 100
Gold, S. M., Kruger, S., Ziegler, K. J., Krieger, T., Schulz, K., Otte, C., & Heesen, C. (2011) · Journal of Neurology Neurosurgery & Psychiatry · doi:10.1136/jnnp.2010.230029 · Cited by 100
Atopic disorders and depression: Findings from a large, population-based study
Sanna, L., Stuart, A. L., Pasco, J. A., Jacka, F. N., Berk, M., Maes, M. H. J., O'Neil, A. E., Girardi, P., & Williams, L. J. (2013) · Journal of Affective Disorders · doi:10.1016/j.jad.2013.11.009 · Cited by 97
Stress-Related Immune Markers in Depression: Implications for Treatment
Hughes, M. M., Connor, T. J., & Harkin, A. (2016) · The International Journal of Neuropsychopharmacology · doi:10.1093/ijnp/pyw001 · Cited by 97
Inflammation modulates anxiety in an animal model of multiple sclerosis
Peruga, I., Hartwig, S., Thöne, J., Hovemann, B. T., Gold, R., Juckel, G., & Linker, R. A. (2011) · Behavioural Brain Research · doi:10.1016/j.bbr.2011.01.018 · Cited by 94
Hoang, H., Laursen, B., Stenager, E. N., & Stenager, E. (2015) · Multiple Sclerosis Journal · doi:10.1177/1352458515588973 · Cited by 90
Yang, T., Wang, L., Deng, X.-Y., & Yu, G. (2017) · Journal of the Neurological Sciences · doi:10.1016/j.jns.2017.07.042 · Cited by 89
Wu, M., Brazier, J. E., Kearns, B., Relton, C., Smith, C., & Cooper, C. L. (2014) · The European Journal of Health Economics · doi:10.1007/s10198-013-0559-z · Cited by 88
Madsen, S., Danneskiold‐Samsøe, B., Stockmarr, A., & Bartels, E. (2015) · Scandinavian Journal of Rheumatology · doi:10.3109/03009742.2015.1095943 · Cited by 85
Fatigue in Patients with Multiple Sclerosis: Is It Related to Pro- and Anti-Inflammatory Cytokines?
Malekzadeh, A., de Geer-Peeters, W. V., de Groot, V., Teunissen, C. E., Beckerman, H., & TREFAMS-ACE Study Group (2015) · Disease Markers · doi:10.1155/2015/758314 · Cited by 81
Benedetti, F., Lucca, A., Brambilla, F., Colombo, C., & Smeraldi, E. (2002) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/s0278-5846(02)00255-5 · Cited by 81
Fatigue in rheumatic disease: an overview
Stebbings, S. M., & Treharne, G. J. (2010) · International Journal of Clinical Rheumatology · doi:10.2217/ijr.10.30 · Cited by 80
Recurrence of depressive disorders after interferon-induced depression
Chiu, W.-C., Su, Y.-P., Su, K.-P., & Chen, P.-C. (2017) · Translational Psychiatry · doi:10.1038/tp.2016.274 · Cited by 80
Brunoni, A. R., Machado‐Vieira, R., Zarate, C. A., Valiengo, L. D. C. L., Vieira, É. L. M., Benseñor, I. M., Lotufo, P. A., Gattaz, W. F., & Teixeira, A. L. (2013) · Psychopharmacology · doi:10.1007/s00213-013-3322-3 · Cited by 76
Dipasquale, O., Cooper, E. A., Tibble, J. A., Voon, V., Baglio, F., Baselli, G., Cercignani, M., & Harrison, N. A. (2015) · Brain Behavior and Immunity · doi:10.1016/j.bbi.2015.12.011 · Cited by 76
Acute Changes in Striatal Microstructure Predict the Development of Interferon-Alpha Induced Fatigue
Dowell, N. G., Cooper, E. A., Tibble, J., Voon, V., Critchley, H. D., Cercignani, M., & Harrison, N. A. (2016) · Biological Psychiatry · doi:10.1016/j.biopsych.2015.05.015 · Cited by 74
Targeting cytokines in reduction of depressive symptoms: A comprehensive review
Shariq, A. S., Brietzke, E., Rosenblat, J. D., Barendra, V., Pan, Z., & McIntyre, R. S. (2018) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/j.pnpbp.2018.01.003 · Cited by 72
Therapeutic interventions in sepsis: current and anticipated pharmacological agents
Shukla, P., Rao, G. M., Pandey, G., Sharma, S., Mittapelly, N., Shegokar, R., & Mishra, P. R. (2014) · British Journal of Pharmacology · doi:10.1111/bph.12829 · Cited by 72
Chen, C., Yeh, Y., Kuo, S.-C., Liang, C., Ho, P., Huang, C., Yen, C.-H., Shyu, J., Lu, R., & Huang, S. (2017) · Psychoneuroendocrinology · doi:10.1016/j.psyneuen.2017.10.009 · Cited by 72
Lin, M., Guo, H., Lu, M., Livneh, H., Lai, N., & Tsai, T. (2015) · Clinics · doi:10.6061/clinics/2015(02)04 · Cited by 67
Mak, A., Tang, C. S., & Ho, R. (2013) · Lupus · doi:10.1177/0961203312471872 · Cited by 65
Prevalence of fatigue in patients with multiple sclerosis and its effect on the quality of life
Nagaraj, K., Taly, A. B., Gupta, A., Prasad, C., & Christopher, R. (2013) · Journal of Neurosciences in Rural Practice · doi:10.4103/0976-3147.118774 · Cited by 64
MicroRNA-155 deletion reduces anxiety- and depressive-like behaviors in mice
Fonken, L. K., Gaudet, A. D., Gaier, K. R., Nelson, R. J., & Popovich, P. G. (2015) · Psychoneuroendocrinology · doi:10.1016/j.psyneuen.2015.10.019 · Cited by 61
Depression in systemic lupus erythematosus, dependent on or independent of severity of disease
van Exel, E. R., Jacobs, J., Korswagen, L.-A., Voskuyl, A. E., Stek, M. L., Dekker, J., & Bultink, I. E. M. (2013) · Lupus · doi:10.1177/0961203313508443 · Cited by 60
Fung, F. Y., Li, M., Breunis, H., Timilshina, N., Minden, M. D., & Alibhai, S. M. H. (2012) · Leukemia Research · doi:10.1016/j.leukres.2012.11.013 · Cited by 53
Th1/Th2 cytokine profile in childhood-onset systemic lupus erythematosus
Postal, M., Peliçari, K. D. O., Sinicato, N. A., Marini, R., Costallat, L. T. L., & Appenzeller, S. (2013) · Cytokine · doi:10.1016/j.cyto.2012.11.023 · Cited by 52
Felger, J. C., Haroon, E., Woolwine, B. J., Raison, C. L., & Miller, A. H. (2015) · Physiology & Behavior · doi:10.1016/j.physbeh.2015.12.013 · Cited by 47
Cytokine Inhibition in Patients With Chronic Fatigue Syndrome: A Randomized Trial
Roerink, M. E., Bredie, S. J. H., Heijnen, M., Dinarello, C. A., Knoop, H., & van der Meer, J. W. M. (2017) · Annals of Internal Medicine · doi:10.7326/m16-2391 · Cited by 47
Alterations of p11 in brain tissue and peripheral blood leukocytes in Parkinson’s disease
Green, H., Zhang, X., Tiklová, K., Volakakis, N., Brodin, L., Berg, L., Greengard, P., Perlmann, T., & Svenningsson, P. (2017) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1621218114 · Cited by 43
Brenner, P., Granqvist, M., Königsson, J., Nimer, F. A., Piehl, F., & Jokinen, J. (2018) · Psychoneuroendocrinology · doi:10.1016/j.psyneuen.2018.01.002 · Cited by 38
Kronfol, Z., Nair, M., Weinberg, V., Young, E. A., & Aziz, M. (2002) · Journal of Affective Disorders · doi:10.1016/s0165-0327(01)00399-8 · Cited by 36
Freire, T. F. V., da Rocha, N. S., & Fleck, M. P. D. A. (2017) · Journal of Psychiatric Research · doi:10.1016/j.jpsychires.2017.05.004 · Cited by 36
Cassol-Jr, O. J., Comim, C. M., Petronilho, F. C., Constantino, L. D. S., STRECK, E. L., Quevedo, J., & Dal‐Pizzol, F. (2010) · Neuroscience Letters · doi:10.1016/j.neulet.2010.02.036 · Cited by 34
Serum Cytokine Levels in Major Depressive Disorder and Its Role in Antidepressant Response
Myung, W., Lim, S.-W., Woo, H. I., Park, J. H., Shim, S., Lee, S.-Y., & Kim, D. K. (2016) · Psychiatry Investigation · doi:10.4306/pi.2016.13.6.644 · Cited by 33
Anxiety and depression in Slovak patients with rheumatoid arthritis
Soósová, M. S., Macejová, Ž., Zamboriová, M., & Dimunová, L. (2016) · Journal of Mental Health · doi:10.1080/09638237.2016.1244719 · Cited by 32
Sorri, A., Järventausta, K., Kampman, O., Lehtimäki, K. A., Björkqvist, M., Tuohimaa, K., Hämäläinen, M., Moilanen, E., & Leinonen, E. V. J. (2018) · Brain and Behavior · doi:10.1002/brb3.933 · Cited by 30
Qiu, W., Wu, M., Liu, S., Chen, B., Pan, C., Yang, M., & Wang, K. (2017) · Toxicology and Applied Pharmacology · doi:10.1016/j.taap.2017.03.002 · Cited by 29
Rogóż, Z., Kubera, M., Rogóż, K., Basta‐Kaim, A., & Budziszewska, B. (2009) · Pharmacological Reports · doi:10.1016/s1734-1140(09)70167-7 · Cited by 25
Psychosocial Stress as a Risk Factor for Sepsis: A Population-Based Cohort Study
Ojard, C., Donnelly, J. P., Safford, M. M., Griffin, R., & Wang, H. E. (2015) · Psychosomatic Medicine · doi:10.1097/psy.0000000000000120 · Cited by 24
Du, Y., Li, B., Zhang, H.-Y., Cao, Y., Duan, X.-H., Gong, W., & Dong, J. (2013) · Journal of Asthma · doi:10.3109/02770903.2013.765891 · Cited by 22
Harrold, L. R., John, A. K., Best, J. H., Zlotnick, S., Karki, C. K., Li, Y., Greenberg, J. D., & Kremer, J. M. (2017) · Clinical Rheumatology · doi:10.1007/s10067-017-3742-2 · Cited by 18
Mehrotra, S., Pecaut, M. J., & Gridley, D. S. (2014) · PubMed · Cited by 12
Cited by
Marx, W., Penninx, B. W. J. H., Solmi, M., Furukawa, T. A., Firth, J., Carvalho, A. F., & Berk, M. (2023) · Nature Reviews Disease Primers · doi:10.1038/s41572-023-00454-1 · Cited by 768
Onset and frequency of depression in post-COVID-19 syndrome: A systematic review
Renaud-Charest, O., Lui, L. M. W., Eskander, S., Ceban, F., Ho, R., Di Vincenzo, J. D., Rosenblat, J. D., Lee, Y., Subramaniapillai, M., & McIntyre, R. S. (2021) · Journal of Psychiatric Research · doi:10.1016/j.jpsychires.2021.09.054 · Cited by 374
Diet and Mental Health: Review of the Recent Updates on Molecular Mechanisms
Godos, J., Currenti, W., Angelino, D., Mena, P., Castellano, S., Caraci, F., Galvano, F., Del Rio, D., Ferri, R., & Grosso, G. (2020) · Antioxidants · doi:10.3390/antiox9040346 · Cited by 258
Immune-mediated inflammatory diseases: common and different pathogenic and clinical features
Monteleone, G., Moscardelli, A., Colella, A., Marafini, I., & Salvatori, S. (2023) · Autoimmunity Reviews · doi:10.1016/j.autrev.2023.103410 · Cited by 105
Biomarkers of post-covid depression
Lorkiewicz, P., & Waszkiewicz, N. (2021) · Journal of Clinical Medicine · doi:10.3390/jcm10184142 · Cited by 102
Metadata
- Authors
- Lee, C.-H., & Giuliani, F.
- Venue
- Frontiers in Immunology
- Publisher
- Frontiers Media SA
- Published
- 2019-07-19
- Volume
- 10
- Pages
- 1696-1696
- ISSN
- 1664-3224 (ISSN-L)
- OpenAlex
- W2961101336
- Cited by
- 640
- References
- 141
- FWCI
- 14.30
- Type
- journal article
- Language
- en
- Open access
- gold
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.